Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 111 articles:
HTML format
Text format



Single Articles


    April 2017
  1. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Text format     Abstract available


  2. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Text format     Abstract available


    March 2017
  3. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Text format     Abstract available


  4. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Text format     Abstract available


  5. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Text format     Abstract available


  6. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Text format     Abstract available


    February 2017
  7. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Text format     Abstract available


  8. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Text format     Abstract available


  9. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Text format     Abstract available


  10. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Text format     Abstract available


  11. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available


  12. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Text format     Abstract available


  13. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Text format     Abstract available


    January 2017
  14. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Text format     Abstract available


  15. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Text format     Abstract available


    December 2016
  16. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Text format     Abstract available


  17. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Text format     Abstract available


  18. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Text format     Abstract available


    November 2016
  19. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Text format     Abstract available


  20. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Text format     Abstract available


  21. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Text format     Abstract available


    October 2016
  22. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Text format     Abstract available


  23. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Text format     Abstract available


  24. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Text format     Abstract available


  25. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Text format     Abstract available


    September 2016
  26. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Text format     Abstract available


  27. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Text format     Abstract available


  28. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Text format     Abstract available


  29. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Text format     Abstract available


    August 2016
  30. CEN L, Xiao Y, Wei L, Mo M, et al
    Association of DYRK1A polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Aug 18. pii: S0304-3940(16)30601.
    PubMed     Text format     Abstract available


    July 2016
  31. MCKEOWN B KIN MD, Peters RM, Pasman EP, McKeown MJ, et al
    Plantar cutaneous function in Parkinson's disease patients ON and OFF L-dopa.
    Neurosci Lett. 2016 Jul 14. pii: S0304-3940(16)30515.
    PubMed     Text format     Abstract available


  32. CROSIERS D, Verstraeten A, Wauters E, Engelborghs S, et al
    Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Neurosci Lett. 2016 Jul 7. pii: S0304-3940(16)30494.
    PubMed     Text format     Abstract available


    June 2016
  33. NAIR VD, Ge Y
    Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum.
    Neurosci Lett. 2016 Jun 28. pii: S0304-3940(16)30470.
    PubMed     Text format     Abstract available


  34. WU H, Lu X, Xie F, Cen Z, et al
    Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30463.
    PubMed     Text format     Abstract available


  35. LI XY, Teng JJ, Liu Y, Wu YB, et al
    Association of AKT1 Gene Polymorphisms with Sporadic Parkinson's disease in Chinese Han Population.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30461.
    PubMed     Text format     Abstract available


  36. LU Q, Song Z, Deng X, Xiong W, et al
    SLC6A3 rs28363170 and rs3836790 variants in Han Chinese patients with sporadic Parkinson's disease.
    Neurosci Lett. 2016 Jun 25. pii: S0304-3940(16)30462.
    PubMed     Text format     Abstract available


  37. KANG SY, Park S, Oh E, Park J, et al
    Vitamin D receptor polymorphisms and Parkinson's disease in a Korean population: Revisited.
    Neurosci Lett. 2016 Jun 21. pii: S0304-3940(16)30450.
    PubMed     Text format     Abstract available


  38. SHIN MS, Jeong HY, An DI, Lee HY, et al
    Corrigendum to "Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson's disease" [Neurosci. Lett. (2016) 28-33].
    Neurosci Lett. 2016 Jun 20. pii: S0304-3940(16)30328.
    PubMed     Text format    


  39. BHATTACHARJEE N, Khairujjaman Mazumder M, Paul R, Choudhury A, et al
    L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
    Neurosci Lett. 2016 Jun 6. pii: S0304-3940(16)30410.
    PubMed     Text format     Abstract available


  40. TARD C, Devanne H, Defebvre L, Delval A, et al
    Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease.
    Neurosci Lett. 2016 Jun 3. pii: S0304-3940(16)30391.
    PubMed     Text format     Abstract available


    May 2016
  41. GEBREMEDHIN KG, Rademacher DJ
    Histone H3 Acetylation in the Postmortem Parkinson's Disease Primary Motor Cortex.
    Neurosci Lett. 2016 May 27. pii: S0304-3940(16)30390.
    PubMed     Text format     Abstract available


  42. GULLY JC, Sergeyev VG, Bhootada Y, Mendez-Gomez H, et al
    Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
    Neurosci Lett. 2016 May 24. pii: S0304-3940(16)30359.
    PubMed     Text format     Abstract available


  43. SWANK C, Mehta J, Criminger C
    Transcranial Direct Current Stimulation Lessens Dual Task Cost in People with Parkinson's Disease.
    Neurosci Lett. 2016 May 12. pii: S0304-3940(16)30309.
    PubMed     Text format     Abstract available


  44. CHEN H, Huang X, Yuan L, Xia H, et al
    A homozygous parkin p.G284R mutation in a Chinese family with autosomal recessive juvenile parkinsonism.
    Neurosci Lett. 2016 May 10. pii: S0304-3940(16)30310.
    PubMed     Text format     Abstract available


    April 2016
  45. WANG X, Zhang X, Xue L, Xie A, et al
    The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
    Neurosci Lett. 2016 Apr 28. pii: S0304-3940(16)30278.
    PubMed     Text format     Abstract available


  46. SOLIMAN AM, Fathalla AM, Moustafa AA
    Dose-Dependent Neuroprotective Effect of Caffeineon a Rotenone-Induced Rat Model of Parkinsonism: A histological study.
    Neurosci Lett. 2016 Apr 27. pii: S0304-3940(16)30279.
    PubMed     Text format     Abstract available


  47. XU Y, Chen Y, Ou R, Wei QQ, et al
    No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population.
    Neurosci Lett. 2016;622:113-117.
    PubMed     Text format     Abstract available


  48. FAN K, Tang BS, Wang YQ, Kang JF, et al
    The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients.
    Neurosci Lett. 2016;621:133-136.
    PubMed     Text format     Abstract available


  49. SHIN MS, Jeong HY, An DI, Lee HY, et al
    Treadmill exercise facilitates synaptic plasticity on dopaminergic neurons and fibers in the mouse model with Parkinson's disease.
    Neurosci Lett. 2016 Apr 11. pii: S0304-3940(16)30220.
    PubMed     Text format     Abstract available


  50. KELM-NELSON CA, Stevenson SA, Ciucci MR
    Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.
    Neurosci Lett. 2016 Apr 4. pii: S0304-3940(16)30208.
    PubMed     Text format     Abstract available


    March 2016
  51. TANIK N, Serin HI, Celikbilek A, Inan LE, et al
    Associations of olfactory bulb and depth of olfactory sulcus with basal ganglia and hippocampus in patients with Parkinson's disease.
    Neurosci Lett. 2016;620:111-114.
    PubMed     Text format     Abstract available


  52. VAN DER MERWE C, Carr J, Glanzmann B, Bardien S, et al
    Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    Neurosci Lett. 2016 Mar 18. pii: S0304-3940(16)30166.
    PubMed     Text format     Abstract available


  53. MITRA S, Ghosh N, Sinha P, Chakrabarti N, et al
    Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Neurosci Lett. 2016;616:86-92.
    PubMed     Text format     Abstract available


    February 2016
  54. EMAMZADEH FN, Aojula H, McHugh P, Allsop D, et al
    Effects of different isoforms of apoE on aggregation of the alpha-synuclein protein implicated in Parkinson's disease.
    Neurosci Lett. 2016 Feb 24. pii: S0304-3940(16)30108.
    PubMed     Text format     Abstract available


  55. FARIAS CC, Maes M, Bonifacio KL, Bortolasci CC, et al
    Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: disease and staging biomarkers and new drug targets.
    Neurosci Lett. 2016 Feb 6. pii: S0304-3940(16)30078.
    PubMed     Text format     Abstract available


    January 2016
  56. GUO Z, Xu S, Du N, Liu J, et al
    Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: involvement of the dopamine system.
    Neurosci Lett. 2016 Jan 28. pii: S0304-3940(16)30047.
    PubMed     Text format     Abstract available


  57. TOUCHETTE JC, Breckenridge JM, Wilken GH, Macarthur H, et al
    Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.
    Neurosci Lett. 2016;612:178-84.
    PubMed     Text format     Abstract available


  58. POLNER B, Moustafa AA, Nagy H, Takats A, et al
    Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's disease.
    Neurosci Lett. 2016 Jan 25. pii: S0304-3940(16)30037.
    PubMed     Text format     Abstract available


  59. YALCINKAYA N, Haytural H, Bilgic B, Ozdemir O, et al
    Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30028.
    PubMed     Text format     Abstract available


  60. YUAN L, Song Z, Deng X, Xiong W, et al
    Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30030.
    PubMed     Text format     Abstract available


  61. ALTMANN V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, et al
    Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Neurosci Lett. 2016 Jan 21. pii: S0304-3940(16)30029.
    PubMed     Text format     Abstract available


    December 2015
  62. ZHANG J, Yang B, Sun H, Zhou Y, et al
    Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Neurosci Lett. 2015 Dec 31. pii: S0304-3940(15)30348.
    PubMed     Text format     Abstract available


  63. CHEN FX, Kang DZ, Chen FY, Liu Y, et al
    Grey Matter Atrophy Associated With Mild Cognitive Impairment in Parkinson's Disease.
    Neurosci Lett. 2015 Dec 29. pii: S0304-3940(15)30346.
    PubMed     Text format     Abstract available


  64. HARRISON IF, Anis HK, Dexter DT
    Associated Degeneration of Ventral Tegmental Area Dopaminergic Neurons in the Rat Nigrostriatal Lactacystin Model of Parkinsonism and their Neuroprotection by Valproate.
    Neurosci Lett. 2015 Dec 29. pii: S0304-3940(15)30343.
    PubMed     Text format     Abstract available


  65. XU J, Zhang J, Wang J, Li G, et al
    Abnormal fronto-striatal functional connectivity in Parkinson's disease.
    Neurosci Lett. 2015 Dec 24. pii: S0304-3940(15)30336.
    PubMed     Text format     Abstract available


  66. TAN T, Song Z, Yuan L, Xiong W, et al
    Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015;612:189-192.
    PubMed     Text format     Abstract available


    November 2015
  67. HE S, Tan T, Song Z, Yuan L, et al
    Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015 Nov 25. pii: S0304-3940(15)30271.
    PubMed     Text format     Abstract available


  68. TOROK R, Zadori D, Torok N, Csility E, et al
    An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.
    Neurosci Lett. 2015 Nov 4. pii: S0304-3940(15)30238.
    PubMed     Text format     Abstract available


    October 2015
  69. NAKASO K, Horikoshi Y, Takahashi T, Hanaki T, et al
    Estrogen receptor-mediated effect of delta-tocotrienol prevents neurotoxicity and motor deficit in the MPTP mouse model of Parkinson's disease.
    Neurosci Lett. 2015 Oct 30. pii: S0304-3940(15)30225.
    PubMed     Text format     Abstract available


  70. SCHIENLE A, Ille R, Wabnegger A
    Experience of negative emotions in Parkinson's disease: an fMRI investigation.
    Neurosci Lett. 2015 Oct 21. pii: S0304-3940(15)30209.
    PubMed     Text format     Abstract available


  71. KALINDERI K, Bostantjopoulou S, Katsarou Z, Dimikiotou M, et al
    D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
    Neurosci Lett. 2015;606:113-6.
    PubMed     Text format     Abstract available


  72. CARVALHO DZ, Schonwald SV, Schumacher-Schuh AF, Braga CW, et al
    Overnight S100B in Parkinson's Disease: A glimpse into sleep-related neuroinflammation.
    Neurosci Lett. 2015 Oct 7. pii: S0304-3940(15)30173.
    PubMed     Text format     Abstract available


    September 2015
  73. ARIZA D, Lopes FN, Crestani CC, Martins-Pinge MC, et al
    CHEMOREFLEX AND BAROREFLEX ALTERATIONS IN PARKINSONISM INDUCED BY 6-OHDA IN UNANESTHETIZED RATS.
    Neurosci Lett. 2015 Sep 23. pii: S0304-3940(15)30150.
    PubMed     Text format     Abstract available


    August 2015
  74. GU C, Shen T, An H, Yuan C, et al
    Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Neurosci Lett. 2015 Aug 18. pii: S0304-3940(15)30089.
    PubMed     Text format     Abstract available


  75. ALDECOA I, Navarro-Otano J, Stefanova N, Sprenger FS, et al
    Alpha-synuclein immunoreactivity patterns in the enteric nervous system.
    Neurosci Lett. 2015;602:145-9.
    PubMed     Text format     Abstract available


  76. HALDER T, Raj J, Sharma V, Das P, et al
    Novel P-TEN-induced putative kinase 1 (PINK1) variant in Indian Parkinson's disease Patient.
    Neurosci Lett. 2015 Aug 14. pii: S0304-3940(15)30091.
    PubMed     Text format     Abstract available


  77. GUO JF, Dong XL, Xu Q, Li N, et al
    Exon dosage analysis of parkin gene in Chinese sporadic Parkinson's disease.
    Neurosci Lett. 2015 Aug 1. pii: S0304-3940(15)30066.
    PubMed     Text format     Abstract available


    July 2015
  78. ZHANG X, Niu M, Li H, Xie A, et al
    RIT2 rs12456492 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2015 Jul 15. pii: S0304-3940(15)30024.
    PubMed     Text format     Abstract available


  79. BRENNER S, Wersinger C, Gasser T
    Transcriptional regulation of the alpha-synuclein gene in human brain tissue.
    Neurosci Lett. 2015;599:140-5.
    PubMed     Text format     Abstract available


    June 2015
  80. PAN X, Chen C, Huang J, Wei H, et al
    Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Neurosci Lett. 2015 Jun 20. pii: S0304-3940(15)00473.
    PubMed     Text format     Abstract available


  81. WEN P, Li M, Xiao H, Ding R, et al
    Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
    Neurosci Lett. 2015 Jun 5. pii: S0304-3940(15)00435.
    PubMed     Text format     Abstract available


    May 2015
  82. CIURLEO R, Bonanno L, Lorenzo GD, Bramanti P, et al
    Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
    Neurosci Lett. 2015 May 22. pii: S0304-3940(15)00409.
    PubMed     Text format     Abstract available


  83. WANG X, Yu S, Li F, Feng T, et al
    Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2015 May 18. pii: S0304-3940(15)00387.
    PubMed     Text format     Abstract available


  84. WANG S, Xu YF, Ding XY, Liu ZR, et al
    Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2015 May 15. pii: S0304-3940(15)00383.
    PubMed     Text format     Abstract available


  85. PREMA A, Janakiraman U, Manivasagam T, Thenmozhi AJ, et al
    Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice.
    Neurosci Lett. 2015 May 14. pii: S0304-3940(15)00381.
    PubMed     Text format     Abstract available


    April 2015
  86. LV Y, Zhang Z, Hou L, Zhang L, et al
    Phytic acid attenuates inflammatory responses and the levels of NFkappaB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Neurosci Lett. 2015 Apr 27. pii: S0304-3940(15)00339.
    PubMed     Text format     Abstract available


  87. XIA J, Xu H, Jiang H, Xie J, et al
    The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2015;595:99-103.
    PubMed     Text format     Abstract available


    March 2015
  88. OHMAN A, Forsgren L
    NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson's disease and controls.
    Neurosci Lett. 2015 Mar 26. pii: S0304-3940(15)00244.
    PubMed     Text format     Abstract available


  89. SAADAT SM, Degirmenci I, Ozkan S, Saydam F, et al
    Is the 1254T>C polymorphism in the DMT1 gene associated with Parkinson's disease?
    Neurosci Lett. 2015 Mar 26. pii: S0304-3940(15)00247.
    PubMed     Text format     Abstract available


  90. CARBUTT S, Duff J, Yarnall A, Burn DJ, et al
    Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease.
    Neurosci Lett. 2015 Mar 26. pii: S0304-3940(15)00241.
    PubMed     Text format     Abstract available


  91. SA F, Zhang LQ, Chong CM, Guo BJ, et al
    Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo.
    Neurosci Lett. 2015 Mar 11. pii: S0304-3940(15)00201.
    PubMed     Text format     Abstract available


  92. BENTEA E, Sconce MD, Churchill MJ, Van Liefferinge J, et al
    MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
    Neurosci Lett. 2015;593:1-6.
    PubMed     Text format     Abstract available


    February 2015
  93. ASANO T, Koike M, Sakata S, Takeda Y, et al
    Possible involvement of iron-induced oxidative insults in neurodegeneration.
    Neurosci Lett. 2015;588:29-35.
    PubMed     Text format     Abstract available


    January 2015
  94. RYCKEWAERT G, Luyat M, Rambour M, Tard C, et al
    Self-perceived and actual ability in the functional reach test in patients with Parkinson's disease.
    Neurosci Lett. 2015 Jan 16. pii: S0304-3940(15)00044.
    PubMed     Text format     Abstract available


  95. BUCHANAN RJ, Gjini K, Darrow D, Varga G, et al
    Glutamate and GABA concentration changes in the globus pallidus internus of Parkinson's patients during performance of implicit and declarative memory tasks: A report of two subjects.
    Neurosci Lett. 2015 Jan 14. pii: S0304-3940(15)00033.
    PubMed     Text format     Abstract available


  96. MIYAJIMA T, Ohta E, Kawada H, Maekawa T, et al
    The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: Possible significance in the transgenic model mouse of Parkinson's disease.
    Neurosci Lett. 2015 Jan 3. pii: S0304-3940(15)00008.
    PubMed     Text format     Abstract available


  97. WIEMERSLAGE L, Lee D
    Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
    Neurosci Lett. 2015;584:342-6.
    PubMed     Text format     Abstract available


    December 2014
  98. KUMARI R, Kumar JB, Luthra PM
    Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Neurosci Lett. 2014 Dec 17. pii: S0304-3940(14)00975.
    PubMed     Text format     Abstract available


  99. LIU Z, Guo J, Li K, Wang Y, et al
    Analysis of several loci from genome-wide association studies in Parkinson's disease in mainland China.
    Neurosci Lett. 2014 Dec 17. pii: S0304-3940(14)00972.
    PubMed     Text format     Abstract available


  100. HAMA Y, Yabe I, Wakabayashi K, Kano T, et al
    Level of plasma neuregulin-1 SMDF is reduced in patients with idiopathic Parkinson's disease.
    Neurosci Lett. 2014;587C:17-21.
    PubMed     Text format     Abstract available


  101. GUSDON AM, Fang F, Chen J, Mathews CE, et al
    Association of the mt-ND2 5178A/C polymorphism with Parkinson's disease.
    Neurosci Lett. 2014 Dec 12. pii: S0304-3940(14)00933.
    PubMed     Text format     Abstract available


  102. SHAO N, Yang J, Shang H
    Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
    Neurosci Lett. 2014 Dec 4. pii: S0304-3940(14)00935.
    PubMed     Text format     Abstract available


  103. GARCIA MC, Cinquina V, Palomo-Garo C, Rabano A, et al
    Identification of CB receptors in human nigral neurons that degenerate in Parkinson's disease.
    Neurosci Lett. 2014 Dec 3. pii: S0304-3940(14)00931.
    PubMed     Text format     Abstract available


    November 2014
  104. COTE SR, Kuzhikandathil EV
    Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson's disease.
    Neurosci Lett. 2014;585C:33-37.
    PubMed     Text format     Abstract available


  105. YOON RG, Kim SJ, Kim HS, Choi CG, et al
    The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: Correlation with F-flurodeoxyglucose positron-emission tomography.
    Neurosci Lett. 2014;584C:296-301.
    PubMed     Text format     Abstract available


    October 2014
  106. ZHOU M, Zhang W, Chang J, Wang J, et al
    Gait analysis in three different 6-hydroxydopamine rat models of Parkinson's disease.
    Neurosci Lett. 2014;584C:184-189.
    PubMed     Text format     Abstract available


  107. AMANO S, Hong SL, Sage JI, Torres EB, et al
    Behavioral inflexibility and motor dedifferentiation in persons with Parkinson's disease: Bilateral coordination deficits during a unimanual reaching task.
    Neurosci Lett. 2014;585C:82-87.
    PubMed     Text format     Abstract available


    August 2014
  108. MALAKOUTI-NEJAD M, Shahidi GA, Rohani M, Shojaee SM, et al
    Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features.
    Neurosci Lett. 2014;577:106-11.
    PubMed     Text format     Abstract available


    July 2014
  109. HU X, Zhang H, Zhang Y, Zhang Y, et al
    Differential protein profile of PC12 cells exposed to proteasomal inhibitor lactacystin.
    Neurosci Lett. 2014;575:25-30.
    PubMed     Text format     Abstract available


    April 2014
  110. WANG YQ, Tang BS, Yu RL, Li K, et al
    Association analysis of STK39, MCCC1/LAMP3 and sporadic PD in the Chinese Han population.
    Neurosci Lett. 2014;566:206-9.
    PubMed     Text format     Abstract available


  111. FLORES AJ, Bartlett MJ, So LY, Laude ND, et al
    Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model.
    Neurosci Lett. 2014;564:48-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: